National Bank of Canada’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $89.1K | Buy |
2,472
+426
| +21% | +$15.3K | ﹤0.01% | 1495 |
|
|
2025
Q1 | $63.7K | Sell |
2,046
-28
| -1% | -$872 | ﹤0.01% | 1510 |
|
|
2024
Q4 | $53K | Buy |
2,074
+371
| +22% | +$9.47K | ﹤0.01% | 1580 |
|
|
2024
Q3 | $48.2K | Buy |
1,703
+78
| +5% | +$2.21K | ﹤0.01% | 1538 |
|
|
2024
Q2 | $42.6K | Buy |
1,625
+87
| +6% | +$2.28K | ﹤0.01% | 1595 |
|
|
2024
Q1 | $43.2K | Sell |
1,538
-33,334
| -96% | -$936K | ﹤0.01% | 1624 |
|
|
2023
Q4 | $986K | Sell |
34,872
-79,441
| -69% | -$2.25M | ﹤0.01% | 1022 |
|
|
2023
Q3 | $3.08M | Buy |
114,313
+15,802
| +16% | +$426K | ﹤0.01% | 780 |
|
|
2023
Q2 | $3.03M | Sell |
98,511
-7,900
| -7% | -$243K | 0.01% | 770 |
|
|
2023
Q1 | $3.82M | Buy |
106,411
+68,765
| +183% | +$2.47M | 0.01% | 589 |
|
|
2022
Q4 | $1.49M | Sell |
37,646
-59,433
| -61% | -$2.35M | ﹤0.01% | 870 |
|
|
2022
Q3 | $3.9M | Buy |
97,079
+72,144
| +289% | +$2.9M | 0.02% | 526 |
|
|
2022
Q2 | $1.07M | Sell |
24,935
-10,249
| -29% | -$438K | ﹤0.01% | 845 |
|
|
2022
Q1 | $1.55M | Buy |
35,184
+12,589
| +56% | +$555K | ﹤0.01% | 793 |
|
|
2021
Q4 | $885K | Buy |
+22,595
| New | +$885K | ﹤0.01% | 947 |
|